The normalization strategy of diagnosis and treatment of post stroke depression

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-13003133

Enrollment

Unknown

Registered

2013-04-03

Start date

2012-09-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poststroke Depression

Interventions

stroke group:antidepressant

poststroke depression group:antidepressant

stroke group:NO

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Participants fulfilled the diagnostic criteria for PSD; (2) Hamilton Depression Rating Scale (HAMD-17) score was greater than 17; (3) the age of onset was 55 years or older,male or female; (4) They were approved by the medical ethics committee for Clinical Research of Zhongda Hospital Affiliated to Southeast University and written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: (1) Take mood stabilizers, antipsychotics, or any anti-depressant medication before this study; (2) Have serious risk of suicide; (3) Have a history of depression or other mental illness history;(4)Have obvious abnormalities laboratory examinations.

Design outcomes

Primary

Measure	Time frame
neuropsychological assessment;Biochemical indicators;	—

Secondary

Measure	Time frame
Efficacy;	—

Countries

China

Contacts

Public ContactYuan Yonggui

yygylh2000@sina.com.cn+86 13913939082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026